NYSE:TBI - Trueblue Stock Price, News, & Analysis

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue announced that its board has initiated a share repurchase plan on Tuesday, October 31st 2017, which authorizes the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

Trueblue Inc (NYSE:TBI) announced its quarterly earnings data on Monday, July, 30th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.49 by $0.08. The business services provider had revenue of $614.30 million for the quarter, compared to analysts' expectations of $601.43 million. Trueblue had a return on equity of 14.66% and a net margin of 2.57%. The business's revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.42 EPS. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, October, 29th 2018. View Earnings Estimates for Trueblue.

Trueblue updated its third quarter earnings guidance on Monday, July, 30th. The company provided earnings per share guidance of $0.75-0.81 for the period, compared to the Thomson Reuters consensus estimate of $0.75. The company issued revenue guidance of $662-677 million, compared to the consensus revenue estimate of $669.25 million.

3 brokers have issued 1 year price targets for Trueblue's shares. Their predictions range from $28.00 to $31.00. On average, they expect Trueblue's share price to reach $29.3333 in the next year. This suggests a possible upside of 2.0% from the stock's current price. View Analyst Price Targets for Trueblue.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Trueblue.

Some companies that are related to Trueblue include Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class B (KELYB), Kelly Services, Inc. Class A (KELYA), SThree (STREF), Barrett Business Services (BBSI), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT), Hudson Global (HSON) and Command Center (CCNI).

Media headlines about TBI stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media and rumor sentiment score of 0.12 on Accern's scale. They also assigned press coverage about the business services provider an impact score of 48.05 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Trueblue.

Trueblue's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.42%), Dimensional Fund Advisors LP (6.27%), FMR LLC (3.07%), Hood River Capital Management LLC (1.93%), Chartwell Investment Partners LLC (1.59%) and Acadian Asset Management LLC (1.45%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Sean A Ebner, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Renaissance Technologies LLC, Tocqueville Asset Management L.P., Algert Global LLC, Russell Investments Group Ltd., Chartwell Investment Partners LLC, Bank of New York Mellon Corp and BlueMountain Capital Management LLC. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Sean A Ebner, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Hood River Capital Management LLC, BlackRock Inc., American Century Companies Inc., LSV Asset Management, Acadian Asset Management LLC, James Investment Research Inc. and Heartland Advisors Inc.. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $28.75.

Trueblue has a market capitalization of $1.17 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]